To evaluate the efficacy of pregabalin, using a flexible, optimized dose schedule with dose
adjustment based on Daily Pain Rating Scale (DPRS), compared to placebo in subjects with
peripheral neuropathic pain.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.